Alessandro Mastroianni

Dr. Alessandro Mastroianni


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2022 in Materials
Verified
Journal Article
Open access
PDF file
FCFrancesco Mattia Ceruso
Francesco Mattia Ceruso
IIIrene Ieria
Irene Ieria
Marco TallaricoMarco Tallarico
Marco Tallarico
Silvio Mario MeloniSilvio Mario Meloni
Silvio Mario Meloni
ALAurea Maria Immacolata Lumbau
Aurea Maria Immacolata Lumbau
MGMarco Gargari
Marco Gargari
To evaluate the implant and prosthetic of two implants with different surfaces and neck design. Enrolled patients received bone level, 12° conical connection implants (Nobel Parallel, Nobel Biocare; NOBEL group) with anodized surface (TiUnite) and roughness of 1.35 μm, or transmucosal implant system (Prama, Sweden and Martina; PRAMA group) with convergent collar, ZIrTi surface, and roughness 1.4–1.7 μm. Both implants were made of pure grade IV titanium, with similar diameter and length, chosen according to the dentistry department availability and patient’s request. After early prosthesis delivery, patients were filled for at least one year. Outcome measures were: implant and prosthetic survival and success rates, physiological marginal bone remodeling, periodontal parameters and pink esthetic score (PES). Results: Fifteen patients were allocated and treated in each group. At the one-year follow-up, three patients dropped out, one in the NOBEL group and two in the PRAMA group. During the entire time of investigation, all implants survived and the prostheses were successful. No statistically significant differences were found in term of marginal bone loss, periodontal parameters, and aesthetics (p > 0.05). Conclusion: With the limitations of the present study, both implant systems showed successful clinical results. Finally, many other clinical and surgical variables may influenced marginal bone levels, implant survival, and periodontal parameters. More homogenous clinical trials with larger samples are needed to confirm these preliminary conclusions.

28 April 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
FCFrancesco Mattia Ceruso
Francesco Mattia Ceruso
ALAurea Maria Immacolata Lumbau
Aurea Maria Immacolata Lumbau
FPFrancesco Pernice
Francesco Pernice
AMAlessandro Mastroianni
Alessandro Mastroianni
MMMichele Miranda
Michele Miranda
MPMilena Pisano
Milena Pisano
Objectives: This retrospective study aimed to evaluate the increase in vertical bone height following sinus lift procedures using the CAS (Crestal Approach Sinus) kit technique in combination with tissue-level implants. Additionally, the quantity of bone between the implant apex and the Schneiderian membrane was assessed to determine the effectiveness and safety of this minimally invasive approach. Methods: The study included 15 patients (20 implants) who underwent sinus lift procedures with the CAS kit technique and tissue-level implants in the posterior maxilla between September 2021 and October 2024. Inclusion criteria required a minimum residual bone height (RBH) of 2 mm. Cone-beam computed tomography (CBCT) scans were used for initial screening, and panoramic radiography evaluated outcomes at implant placement and nine months postoperatively. Primary outcomes included implant and prosthetic survival rates, as well as biological and technical complications. Secondary outcomes were vertical bone height and the amount of bone above the implant tip. Statistical analyses were conducted using the Wilcoxon signed-rank test with a significance level of 0.05. Results: All implants achieved successful osseointegration, with no implant or prosthetic failures and no biological or technical complications reported. The mean RBH at implant placement was 4.2 ± 1.4 mm, which increased to an overall membrane elevation of 13.8 ± 1.8 mm. At the 9-month follow-up, the overall membrane elevation was slightly reduced to 13.0 ± 1.6 mm (p = 0.000), with a mean bone gain of 9.6 ± 2.4 mm. The amount of bone above the implant tip was 3.4 ± 1.7 mm at placement, decreasing to 3.0 ± 1.2 mm at follow-up (p = 0.007). Conclusions: The CAS kit technique combined with tissue-level implants demonstrated significant vertical bone gain and high implant survival rates without complications. This minimally invasive approach proved effective and safe for sinus augmentation in patients with limited residual bone height. The findings support the CAS kit’s potential as a preferred technique for maxillary sinus elevation. Further research with larger cohorts and long-term follow-up is needed to validate these results.

5 November 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
FCFrancesco Mattia Ceruso
Francesco Mattia Ceruso
FPFrancesco Pernice
Francesco Pernice
MGMarco Gargari
Marco Gargari
CFCarola Di Frischia
Carola Di Frischia
AMAlessandro Mastroianni
Alessandro Mastroianni
EXErta Xhanari
Erta Xhanari
Background/Objectives: Maxillary sinus floor elevation is a well-established procedure for enabling implant placement in the posterior maxilla when residual bone height is insufficient. Minimally invasive transcrestal techniques, including the use of the Crestal Approach Sinus (CAS) kit, have been developed to reduce surgical morbidity while maintaining predictable clinical outcomes. The aim of this retrospective comparative study was to evaluate the clinical and radiographic outcomes of transcrestal sinus floor elevation performed using the CAS kit in patients presenting with residual bone height below or above 4 mm. Methods: Forty-five partially edentulous patients who received single implant-supported rehabilitations in the posterior maxilla between September 2021 and October 2024 were included. Patients were allocated to a test group (residual bone height < 4 mm; n = 20) and a control group (residual bone height ≥ 4 mm; n = 25). All procedures were performed using a standardized CAS-kit protocol with hydraulic membrane elevation and xenogeneic bone grafting. The primary outcomes were implant and prosthetic survival rates and the occurrence of biological or technical complications. Secondary outcomes included the radiographic evaluation of residual bone height, final bone height, vertical bone gain, and bone height above the implant apex at implant placement, prosthetic delivery (9 months) and at the 2 years follow-up. Results: No implant or prosthetic failures and no biological or technical complications were recorded, resulting in 100% implant and prosthetic survival rates. Residual bone height was significantly lower in the test group (2.8 ± 0.8 mm) than in the control group (5.3 ± 1.0 mm) (p < 0.001). Despite significantly greater vertical bone gain in the test group (10.9 ± 1.6 mm vs. 8.2 ± 0.6 mm; p < 0.001), comparable final bone heights were observed immediately after augmentation (13.7 ± 1.7 mm vs. 13.5 ± 1.5 mm; p = 0.742) and at prosthetic delivery (12.6 ± 1.6 mm vs. 12.9 ± 1.6 mm; p = 0.556). Bone height above the implant apex was also similar between the groups at both time points. A modest but statistically significant reduction in augmented bone height was observed during healing in both groups. Conclusions: Within the limitations of this retrospective study, transcrestal sinus floor elevation using the hydraulic CAS-kit technique showed favorable clinical and radiographic outcomes in both groups, including sites with residual bone height below 4 mm. These preliminary findings suggest that the crestal approach may represent a treatment option in carefully selected patients with limited residual bone height. However, larger prospective controlled studies with standardized radiographic assessments and longer follow-up periods are needed to confirm these findings.